党参:民族药理学、植物化学、药效学、药代动力学、毒性及潜在临床应用的综合综述
该综述系统检索1993至2025年中英文文献,整合党参的民族药理学、植物化学、药效学、药代动力学与毒性信息。党参含超100种化合物、至少21类,具免疫、胃肠保护、改善学习记忆、抗炎抗氧化等活性,涉及PI3K/Akt等通路,活性成分吸收慢、生物利用度中等,主要分布于胃肠、肝、肾且代谢负担较低。
要点
- 党参为经典补气药及药食同源品种,药典收载三种基原。
- 党参活性涉及免疫、胃肠、记忆、抗炎抗氧化,关联多条信号通路。
- 党参活性成分吸收慢、生物利用度中等,肝肾功能负担较低。
核心结论
- 党参从经典记录到现代研究获全面综述,整合多领域证据以阐明已知、界定未解问题并提出后续研究框架。
研究设计与样本
- 系统文献综述,检索《本草纲目》等经典及PubMed、ScienceDirect、Springer、Web of Science、ACS、SCOPUS、CNKI、CSTJ、WANFANG数据库。
- 检索范围限1993至2025年中英文出版物,主题为党参的化学成分、鉴定、药理活性、药代动力学、毒性及临床应用。
主要发现
- 党参、素花党参和川党参是《中国药典》收载的党参法定药用物种。
- 党参中已鉴定超过100种化合物,涵盖至少21类。
- 党参及活性成分具增强免疫、保护胃肠、改善学习记忆、抗炎和抗氧化作用。
- 党参广泛活性与调控PI3K/Akt、MAPK/NF-κB、TLR4/NF-κB和AMPK/PGC-1α信号通路直接相关。
- 党参活性成分(如多糖、皂苷等)体内吸收缓慢、生物利用度中等,主要分布于胃肠道、肝、肾,代谢过程对肝肾负担较低。
关键数值与推荐
- 党参、素花党参和川党参为《中国药典》收载的法定药用物种。
- 党参中已鉴定超过100种化合物,涵盖至少21类。
- 党参广泛活性与PI3K/Akt、MAPK/NF-κB、TLR4/NF-κB和AMPK/PGC-1α信号通路调控直接相关。
- 党参活性成分吸收缓慢、生物利用度中等,主要分布于胃肠道、肝、肾,代谢对肝肾负担较低。
临床怎么用
- 可依据药典基原鉴别党参药材,关注党参、素花党参和川党参三种法定来源。
- 党参补气功效与其免疫增强、胃肠保护、改善学习记忆、抗炎抗氧化活性相关,可辨证用于相应证候。
- 党参活性成分吸收慢、生物利用度中等且肝肾代谢负担较低,组方用药时需考虑其药代特征。
局限性
- 现有研究分散于不同领域,综述旨在整合信息,但原始研究的异质性与质量未在摘要中详述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Codonopsis Radix, referred to as Dangshen, is a classic qi-tonifying herb in traditional Chinese medicine theory and is also officially recognized as an edible Chinese herbal. Modern scientific research has conducted numerous studies on Codonopsis Radix, but these explorations are scattered across diverse fields. PURPOSE: This paper aims to integrate the information regarding the ethnopharmacology, phytochemistry, pharmacokinetics, toxicity and particularly the pharmacodynamics of Codonopsis Radix to clarify its underlying mechanisms and provide guidance for its future investigation. METHODS: This paper conducted a systematic literature by retrieving Codonopsis Radix, chemical components, herbal verification, pharmacological activities, pharmacokinetics, toxicity and clinical applications within classic works such as Compendium of Materia Medica and databases including PubMed, ScienceDirect, Springer, Web of Science, ACS, SCOPUS, CNKI, CSTJ, and WANFANG. The search scope was limited to Chinese and/or English publications from 1993 to 2025. RESULTS: Codonopsis pilosula (Franch.) Nannf., Codonopsis pilosula (Franch.) Nannf. var. modesta (Nannf.) l. T. Shen, and Codonopsis tangshen Oliv. are the official medicinal species of Codonopsis Radix documented in the Chinese Pharmacopoeia. To date, over 100 distinct compounds, encompassing at least 21 classes, have been identified in Codonopsis Radix. Although lobetyolin is regarded as its characteristic component, evidences have found that codonopyrrolidum A/B and tangshenoside I are the key substances for identifying different sources of Codonopsis Radix. Research has confirmed that Codonopsis Radix and its active components have powerful effects in cementing immunity, protecting the stomach and intestines, improving learning and memory, anti-inflammation and anti-oxidant. Pharmacological investigations have shown that the broad-spectrum activities of Codonopsis Radix are directly related to the regulation of PI3K/Akt, MAPK/NF-κB, TLR4/NF-κB and AMPK/PGC-1α signaling pathways. The active components of Codonopsis Radix (such as polysaccharides, saponins, etc.) are absorbed slowly in the body with moderate bioavailability. And they are mainly distributed in the gastrointestinal tract, liver, kidneys, and the metabolic process has a relatively low burden on the liver and kidneys. CONCLUSION: In summary, our findings provide a comprehensive review of Codonopsis Radix, tracing its journey from classical records to the latest scientific reports. Through an integrated analysis of research across various domains, we expect to elucidate the established works, define the unresolved questions and propose a strategic framework for subsequent studies.
引用
- Bai J, Xie N, Hou Y, et al. Codonopsis Radix: A comprehensive review for its ethnopharmacology, phytochemistry, pharmacodynamics, pharmacokinetics, toxicity and potential clinical applications. Phytomedicine. 2025. PMID: 41275746. doi:10.1016/j.phymed.2025.157540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。